These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting. Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Penisular Malaysia. Hassan SA; Othman N; Idris FM; Abdul Rahman Z; Maning N; Abdul Rahman R; Tiong CG Med J Malaysia; 2012 Aug; 67(4):402-5. PubMed ID: 23082450 [TBL] [Abstract][Full Text] [Related]
29. [Infection rate and clinical characteristics of toxigenic Li D; Guo S; Guan DX; Zhao CN; Xu XW Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):564-569. PubMed ID: 32605340 [No Abstract] [Full Text] [Related]
30. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424 [TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170 [TBL] [Abstract][Full Text] [Related]
33. [Six years evaluation of Clostridium difficile associated diarrhea]. Ercis S; Ergin A; Hasçelik G Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901 [TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Banaszkiewicz A; Kowalska-Duplaga K; Pytrus T; Pituch H; Radzikowski A Inflamm Bowel Dis; 2012 May; 18(5):844-8. PubMed ID: 21936029 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001 [TBL] [Abstract][Full Text] [Related]
36. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers. Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466 [TBL] [Abstract][Full Text] [Related]
37. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Vaishnavi C; Thapa BR; Thennarasu K; Singh K Indian J Pathol Microbiol; 2002 Jan; 45(1):69-73. PubMed ID: 12593568 [TBL] [Abstract][Full Text] [Related]
38. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study. Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924 [TBL] [Abstract][Full Text] [Related]
39. Serum bacterial toxins are related to the progression of inflammatory bowel disease. Qiu H; Sun X; Sun M; He C; Li Z; Liu Z Scand J Gastroenterol; 2014 Jul; 49(7):826-33. PubMed ID: 24853095 [TBL] [Abstract][Full Text] [Related]
40. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards. Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]